Abstract:Aim: To observe the therapeutic efficacy and prognostic factors that influence survival rates in non-small cell lung cancer (NSCLC) patients with multiple brain metastases (BMs), (more than three and less than ten).Methods: Retrospective analyses were conducted on the clinical data of 209 NSCLC patients with multiple BMs and were admitted to our hospital between March 2007 and November 2012. All BM patients received whole-brain radiotherapy. Two hundred patients received combined chemotherapy during the treatment process; 99 received targeted drug therapy; and nine got only symptomatic and supportive treatment. Survival time was defined as the period from the start of BM therapy to the patient's death or end of the follow-up period. The Kaplan-Meier method was used to calculate the median survival time, and the 6-month, 1-, and 2-year cumulative survival rates, as well as to plot the survival curves. The patients' cultural background included their socioeconomic status, level of education, their understanding of the disease, and the degree of care and support they received from their family members. Log-rank test was employed to test the differences in the survival rates between the subgroups. Cox multivariate regression analyses were used to analyze the various factors influencing the prognoses of NSCLC with multiple BMs.Results: The follow-up duration was between 1 and 87 months. The median survival time for all BM patients was 12.1 months (95% confidence interval 9.37-14.83). The 6-month, 1-, and 2-year cumulative survival rates were 80%, 50.2%, and 10.7%, respectively. Univariate analyses revealed that the independent factors influencing survival prognoses included Karnofsky Performance Status score, control of the primary lung tumor, interval between the confirmed diagnoses of lung cancer and BM, presence of extracranial metastasis, number of chemotherapy cycles undergone, Graded Prognostic Assessment class, administration of combined targeted drug therapy, the pathological type, and the cultural backgrounds of the patients. Multivariate analyses indicated that the number of chemotherapy cycles, administration of combined drug therapy, and patients' cultural background were key independent factors influencing survival prognoses.Conclusion: Active treatment of NSCLC with multiple BMs was beneficial, and the patients' cultural background had a strong influence on survival prognoses. Chemotherapy combined with targeted drug therapy could increase the patients' median and overall survival rates. The number of chemotherapy cycles undergone, administration of combined targeted drug therapy, and the cultural backgrounds of the patients had significant effects on the patients' survival prognoses.

Therapeutic Efficacy of Different Radiation Treatments for Multiple Brain Metastases from Lung Cancer

Analysis of Whole Brain Radiotherapy Plus Stereotactic Radiosurgery in Treatment of Brain Metastases from Lung Cancer

The Analysis of Effect about Different Therapies on Brain Metastases from Non-Small Cell Lung Cancer

Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors

Radiotherapy in Different Doses for Non-Small Cell Lung Cancer Patients with Brain Metastasis-Phase Ⅰ-Ⅱ Study

Clinical research of SRT and 3D-CRT on treatment of brain metastasis form lung cancer

Whole brain radiotherapy plus chemotherapy in the treatment of brain metastases from lung cancer: A metaanalysis of 19 randomized controlled trails

Analyses of Prognostic Factors in Cases of Non-Small Cell Lung Cancer with Multiple Brain Metastases

Analysis of therapy effiency affecting 3-Dimentional Conformal radiotherapy after brain metastases from lung cancer

The Therapeutic Sequence of Whole Brain Radiotherapy for the Newly Diagnosed Non-Small Cell Lung Cancer Patients with Asymptomatic Brain Metastasis

X-ray stereotactic radiosurgery for brain metastases

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis.

Evalauation Effects of Radiotherphy for Brain Metastases of Non-Small-cell Lung Carcinoma and Muti-Factor Analysis of the Prognosis

Clinic analysis of non-small cell lung cancer with brain metastasis

Efficacy of Three-Dimensional Conformal Radiation Therapy in Treatment of Brain Metastasis of Lung Cancer

Therapeutic efficacy of multiple brain matastases treatment with linear accelerator radiosurgery alone

Meta-analysis of stereotactic radiosurgery with or without whole-brain radiotherapy for patients presenting brain metastases

Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy

Effect of whole-brain radiotherapy plus rotating Gamma Knife in patients with brain metastasis from lung cancer

[Analysis of Prognostic Factors for 63 Patients with Brain Metastasis from Lung Cancer after Radiochemotherapy].

Whole-Brain Radiation Therapy With Simultaneous Integrated Boost Versus Whole-Brain Radiation Therapy Plus Stereotactic Radiosurgery for the Treatment of Brain Metastasis From Lung Cancer